Page last updated: 2024-11-05

trifluoperazine and Malaria

trifluoperazine has been researched along with Malaria in 2 studies

Malaria: A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cabrera, DG1
Horatscheck, A1
Wilson, CR1
Basarab, G1
Eyermann, CJ1
Chibale, K1
Miki, A1
Tanabe, K1
Nakayama, T1
Kiryon, C1
Ohsawa, K1

Other Studies

2 other studies available for trifluoperazine and Malaria

ArticleYear
Plasmodial Kinase Inhibitors: License to Cure?
    Journal of medicinal chemistry, 2018, 09-27, Volume: 61, Issue:18

    Topics: Antimalarials; Humans; Malaria; Plasmodium; Protein Kinase Inhibitors; Protein Kinases

2018
Plasmodium chabaudi: association of reversal of chloroquine resistance with increased accumulation of chloroquine in resistant parasites.
    Experimental parasitology, 1992, Volume: 74, Issue:2

    Topics: Animals; Antidepressive Agents, Tricyclic; Calcium Channel Blockers; Chloroquine; Chlorpromazine; Ch

1992